Antibodies Market Analysis

1
Antibodies Market
2
The global antibodies market is estimated to
account for US 147,385.1 Mn in terms of value
and is expected to reach US 384,011.6 Mn by the
end of 2027. Antibody, also called
as immunoglobulin, is a protein produced by
plasma cells in response to specific antigens.
These Antibodies can be used as therapeutic as
well as diagnostic purposes for several
indications, including cancers, autoimmune
disorders, inflammatory infectious diseases and
others.
3

1. The adoption of antibody-based drugs for the
   treatment of cancer has significantly
   increased. Monoclonal antibody therapeutics offer
   high specificity, activity, favorable
   pharmacokinetics, and standardized manufacturing
   processes.
2. Moreover, antibodies can increase immune response
   against cancer cells through complement-dependent
   cytotoxicity or antibody dependent cellular
   cytotoxicity.
3. The use of antibodies as a diagnostic reagents
   for the identification of disease markers or
   proteins based on immunoassays has decreased.
4. This is attributed to increasing accuracy of
   molecular diagnostic tools.

4

• For more details, visit-https//cmiblogdailydose.b
  logspot.com/2022/07/antibodies-component-of-immune
  e-system.html
• Global Antibodies Market Competitive Landscape
• Novartis AG, F. Hoffmann-La Roche Ltd., Johnson
  Johnson Services, Inc., Takeda Pharmaceutical
  Company Limited, Amgen Inc., Biogen Inc.,
  Bristol-Myers Squibb Company, AbbVie Inc.,
  Sanofi, Eli Lilly and Co., Iovance
  Biotherapeutics, Inc., Ultragenyx Pharmaceutical
  Inc. and Kyowa Kirin Co., Ltd.

5
Thank You!